Biosynthesis: Proprietary Cannabinoid Manufacturing
InMed is developing a robust, high-yield biosynthesis process for manufacturing ALL 90+ naturally-occurring cannabinoids. This process combines the inherent safety and known efficacy of the natural drug structures with the convenience, control and quality of a laboratory-based manufacturing process.
InMed is modifying the agriculture based grow-harvest-extract-purify thinking of cannabinoid raw material manufacturing and entering the 21st Century.
Benefits of Biosynthesis:
- Significant cost savings vs. existing crop grow-harvest-extract-purify methods
- Easier path for Scale-up and Systems Optimization
- Enhanced Production, Purification, Quality Control and structural integrity versus other chemical manufacturing methods
- Access to minor cannabinoids that are currently economically unfeasible to extract from plant sources & develop into drug candidates
Biosynthesis is used in multiple industrial applications, including use of bacteria or yeast-based systems for the production of pharmaceuticals.
Millions of diabetics worldwide use biosynthesis-sourced insulin to regulate their blood sugar levels each day.
InMed’s biopharmaceutical approach to the production of pharmaceutical grade, bio-identical cannabinoids is a disruptive technology in the current and rapidly emerging cannabinoid pharmaceutical sector.
Sample industrial biofermentation facility.
Bioinformatics / R&D
Keep Up to date!
Get all the latest news & information about InMed...